Date Posted: Nov 17, 2017
Application Deadline: Open Until Filled
- Zhejiang university
- Location: Hangzhou, China
- Job Number: 7048943
- Posting Date: Nov 17, 2017
- Application Deadline:
Open Until Filled
ZJU regenerative medicine group mainly focuses on the use of stem cells, biomaterials and tissue engineering in the field of musculoskeletal science to create novel therapeutic strategies for tissue regeneration. Detailed information can be found in http://term.zju.edu.cn/english/.
Prof. H-W. Ouyang invites applicants for multiple postdoctoral positions in the areas of:
- Tendon Diseases and Regeneration
- Osteoarthritis and Cartilage Regeneration
- Biomaterials and Scaffold Development
- Stem Cell Amplification Technology
Zhejiang University located in Hangzhou, one of the most beautiful cities in China, ranks as one of the top research institutions in China and demonstrates its academic excellence with rapidly rising presence in global university ranking. We provide a collaborative research environment and access state-of-the-art infrastructures and core facilities at Zhejiang School of Medicine. Currently, there are foreign faculty members and postdoctoral fellows conducting cutting-edge research in the School.
Candidates should have excellent academic qualifications, good writing and communication skills, teamworking spirit, strong responsibility and feel comfortable in interdisciplinary environment. Candidates with prior experience with stem cells and regenerative medicine (stem cell biology, tissue engineering, biomaterials, bioinformatics, genome editing using CRISPR Cas9 technology…) are particularly welcome.
Qualified applicants will be offered international competitive salary (35,000~50,000 USD dollars/year) by Li Dak Sum Postdoc Fellowships, start-up funding, and other benefits which are commensurate with qualifications and experience.
Applicants should submit a cover letter, curriculum vitae, and the names of three references to:
A/Prof. LIU Hua
Regenerative medicine group, School of Medicine, Zhejiang University
Hangzhou, Zhejiang Province, China 310058
Yin, Z et al., Single-cell analysis reveals a nestin(+) tendon stem/progenitor cell population with strong tenogenic potentiality, SCIENCE ADVANCES, 2016.
Jun, Dai. et al., Kdm6b regulates cartilage development and homeostasis through anabolic metabolism. ANNALS OF THE RHEUMATIC DISEASES, 2016.
Hu, J.-J. et al., Pharmacological Regulation of In Situ Tissue Stem Cells Differentiation for Soft Tissue Calcification Treatment. STEM CELLS, 2016.
Chen, PF et al., Radially oriented collagen scaffold with SDF-1 promotes osteochondral repair by facilitating cell homing,
Liu, HH et al., Mohawk Promotes the Tenogenesis of Mesenchymal Stem Cells Through Activation of the TGF beta Signaling Pathway, STEM CELLS, 2015.
Wang, JJ et al., Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis, BIOMATERIALS, 2015.
Chen, X et al., Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway, BIOMATERIALS, 2015.
Zhang, C et al., Well-aligned chitosan-based ultrafine fibers committed teno-lineage differentiation of human induced pluripotent stem cells for Achilles tendon regeneration, BIOMATERIALS, 2015.
Zhu, S., et al., Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo. ANNALS OF THE RHEUMATIC DISEASES. 2015.
Wu, Y. et al., A Bi-Lineage Conducive Scaffold for Osteochondral Defect Regeneration. ADVANCED FUNCTIONAL MATIRIALS. 2014
Dr. Junfeng Ji’s research focuses on stem cell biology. It branches out into two directions: 1) pluripotency and somatic reprogramming; 2) stem cell aging. The laboratory is particularly interested in understanding the molecular signals including epigenetic modifiers, metabolites and signaling molecules that control stem cell fate decision. The laboratory has demonstrated track record in this exciting field by publications in high-rank journal such as Stem Cell Reports (Cover Story), Stem Cells and Journal of Cell Science etc.
The successful candidates must possess a PhD or MD/PhD. Molecular biology and epigenetic experience are preferred. Prior experience with stem cell and regenerative medicine is desirable but not essential. Applicants should submit a cover letter, curriculum vitae, and the names of three references to:
Junfeng Ji, MD. PhD
Centre of Stem Cells and Regenerative Medicine School of Medicine, Zhejiang University
Hangzhou, Zhejiang Province, China 310058
Only the selected candidates will be contacted.